BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30843422)

  • 1. Acupuncture at PC6 prevents cardiac hypertrophy in isoproterenol-treated mice.
    Zhang M; Du Q; Yang F; Guo Y; Hou Y; Zhu P
    Acupunct Med; 2019 Feb; 37(1):55-63. PubMed ID: 30843422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of electroacupuncture on myocardial transient receptor potential channels in mice with myocardial hypertrophy.
    Xie YH; Xing XY; Zhong W; Wu SB; Zhou MQ; Cui S
    Zhen Ci Yan Jiu; 2024 Jun; 49(6):558-565. PubMed ID: 38897799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of cardiac remodeling model in FVB/N mice by intraperitoneal injection of isoproterenol].
    Yuan YH; Zheng XM; He XH; Liu LP; Xu W; Xia XH; Luo JH; Lyu M; Zhu QL; Wang S; Wu S
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jun; 20(6):508-513. PubMed ID: 29972128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
    Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
    Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of a FVB/N mouse model of cardiac hypertrophy by isoprenaline].
    Yang CZ; Tian AJ; Meng ZH; Wu JM; Zhang YY; Guo LJ; Li ZJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 46(6):906-10. PubMed ID: 25512281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schisandrin A protects against isoproterenol‑induced chronic heart failure via miR‑155.
    Gao L; Li T; Li S; Song Z; Chang Y; Yuan L
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34812475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway.
    Mao HP; Wang XY; Gao YH; Chang YX; Chen L; Niu ZC; Ai JQ; Gao XM
    J Ethnopharmacol; 2016 Jun; 186():20-29. PubMed ID: 26970569
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
    Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of sinomenine on isoproterenol-induced cardiac hypertrophy in mice.
    Li L; Fang P; Chen J; Zhang C; Tao H
    J Appl Biomed; 2021 Sep; 19(3):142-148. PubMed ID: 34907757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
    Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways.
    Song R; Xiong C; Bai J; Bai Z; Liu W
    Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 38258596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and bioinformatics analysis of miRNA in ISO-induced rat cardiac hypertrophy].
    Wu XC; Zhao Y; Li C; Xiong HR; Zheng ZW; Zhou J; Liu R; Gong W; Liu CQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Sep; 35(5):476-480. PubMed ID: 31894683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Gonadectomy and Angiotensin II Receptor Blockade in a Mouse Model of Isoproterenol-induced Cardiac Diastolic Dysfunction.
    Asai K; Murai K; Shirakabe A; Kamiya M; Noma S; Sato N; Mizuno K; Shimizu W
    J Nippon Med Sch; 2021 May; 88(2):113-120. PubMed ID: 32475904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plantago asiatica L. seeds extract protects against cardiomyocyte injury in isoproterenol- induced cardiac hypertrophy by inhibiting excessive autophagy and apoptosis in mice.
    Fan W; Zhang B; Wu C; Wu H; Wu J; Wu S; Zhang J; Yang X; Yang L; Hu Z; Wu X
    Phytomedicine; 2021 Oct; 91():153681. PubMed ID: 34371252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acupuncture at Neiguan (PC 6) on cardiac function using echocardiography in myocardial ischemia rats induced by isoproterenol.
    Wang S; Ren L; Jia L; Gu Z; Fan X; Chen W; Hou P; Liang F; Rong P; Ma T; Liu X; Chen Y
    J Tradit Chin Med; 2015 Dec; 35(6):653-8. PubMed ID: 26742310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling.
    Li W; Gan R; Sun G
    Chin Med J (Engl); 2002 Aug; 115(8):1166-9. PubMed ID: 12215284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
    Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
    Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.